This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Transmission of infection

Authoring team

The transmission of infectious agents is a small but serious risk of blood transfusion. Possible agents include:

  • hepatitis B and C - blood donations are now screened for these agents. The surface antigen, HBsAg, forms the basis of screening for hepatitis B virus and occasionally transmission may take place because a donor is in an early phase of infection before antigen is detectable

  • CMV - may occur as the virus can remain dormant in leukocytes. Immunocompromised patients without anti-CMV antibodies, and neonates, should be given blood from CMV-negative donors only

  • HIV-1 - donated blood is screened for anti-HIV antibodies but there remains a very small risk of transmission - estimated at 1 in 300,000 units transfused - since antibody may not yet have developed in the donor

  • infectious mononucleosis may occasionally be transmitted

  • syphilis transmission is rare as all donations are screened for treponemal infections and the infectivity of Treponema pallidum declines as blood is stored at 2 - 6 degrees C

  • malaria - rare in the UK as the method of donor selection is designed to exclude potentially infectious donors. It is more likely in endemic areas in which anti-malarial drugs are advised for blood recipients

  • other rare potential contaminants include brucella, plasmodia, trypanosomes

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.